v3.26.1
COMMITMENTS AND CONTINGENCIES - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Sep. 30, 2024
Jun. 30, 2026
Jun. 30, 2025
Dec. 31, 2025
Loss Contingencies [Line Items]            
Litigation settlement, fee expense $ 13,950 $ 0   $ 13,950 $ 0  
Upfront fee related to technology license agreement     $ 15,000      
Acquired in-process research and development 299 1,698   595 1,994  
Impairment charges 0 2,479   0 2,479  
Internal-use software in service            
Loss Contingencies [Line Items]            
Impairment charges   2,500     2,500  
Convertible Notes            
Loss Contingencies [Line Items]            
Cancellation of convertible promissory notes       40,000    
Convertible Notes | BioIntelliSense, Inc.            
Loss Contingencies [Line Items]            
Cancellation of convertible promissory notes       10,000    
Acquired in-process research and development 300 $ 1,700   600 $ 2,000  
Milestone Notes            
Loss Contingencies [Line Items]            
Cancellation of convertible promissory notes       20,000    
Class Action            
Loss Contingencies [Line Items]            
Payments for legal settlements 45,000          
Accrued liabilities 45,000     45,000    
Estimated insurance recoveries 40,000     40,000    
Estimated insurance recoveries, incurred 9,000     9,000    
Litigation settlement, fee expense       31,000    
Insurance recoveries       4,100    
Litigation settlement, fee expense, net 14,000     14,000    
Location, Statement of Financial Position, Balance [Axis]: us-gaap:AccruedLiabilitiesCurrent            
Loss Contingencies [Line Items]            
Accrued health benefits liability $ 3,000     $ 3,000   $ 2,600